Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Hui Liu

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Anticancer Research|January 31, 2012
Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancerChien-Yu Lin, Cheng-Mao Ho, Da-Tian Bau, et al.
Oncotarget|April 2, 2016
Docosahexaenoic acid inhibits 12-O-tetradecanoylphorbol-13- acetate-induced fascin-1-dependent breast cancer cell migration by suppressing the PKCδ- and Wnt-1/β-catenin-mediated pathwaysChong-Kuei Lii, Jer-Wei Chang, Jia-Jing Chen, et al.
Hu Li Za Zhi the Journal of Nursing|August 2, 2021
[Driving Cessation and Mental Health in Persons With Dementia: A Preliminary Study]Shu-Hui Liu, Chia-Chi Chang, Chaur-Jong Hu, et al.
Scientific Reports|August 6, 2017
Targeting primary acute myeloid leukemia with a new CXCR4 antagonist IgG1 antibody (PF-06747143)Yanyan Zhang, Erika Saavedra, Ruoping Tang, et al.
Bioconjugate Chemistry|February 3, 2017
Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug ConjugatesRachel M DeVay, Kathy Delaria, Guoyun Zhu, et al.
Journal of Translational Medicine|April 24, 2025
MUC18-Directed chimeric antigen receptor T cells for the treatment of mucosal melanomaFenghao Zhang, Haizhen Du, Kaiping Liu, et al.
Molecular Cancer Therapeutics|April 17, 2026
ADCE-T02 - a Next Generation Antibody Drug Conjugate Targeting Tissue Factor Demonstrates Superior Preclinical Efficacy and TolerabilityThomas T Poulsen, Olga Ilina, Jonathan H Wardman, et al.
The Journal of Organic Chemistry|October 13, 2020
One-Pot CuI/DBU-Catalyzed Carboxylative Cyclization toward Oxazolidinones Using Recyclable Molecular Sieves as Efficient Promoters for Fixation of CO<sub>2</sub> in Water MediumYu-Te Liu, Chi-Wei Cheng, Huan-Chang Lu, et al.
Cancer Research|September 5, 2023
A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody-Drug Conjugate for Targeting MelanomaJing Shi, Tao Jiao, Qian Guo, et al.
Molecular Cancer Therapeutics|September 2, 2016
RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor ModelsPavel Strop, Thomas-Toan Tran, Magdalena Dorywalska, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Anticancer Research|January 31, 2012
Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancerChien-Yu Lin, Cheng-Mao Ho, Da-Tian Bau, et al.
Oncotarget|April 2, 2016
Docosahexaenoic acid inhibits 12-O-tetradecanoylphorbol-13- acetate-induced fascin-1-dependent breast cancer cell migration by suppressing the PKCδ- and Wnt-1/β-catenin-mediated pathwaysChong-Kuei Lii, Jer-Wei Chang, Jia-Jing Chen, et al.
Hu Li Za Zhi the Journal of Nursing|August 2, 2021
[Driving Cessation and Mental Health in Persons With Dementia: A Preliminary Study]Shu-Hui Liu, Chia-Chi Chang, Chaur-Jong Hu, et al.
Scientific Reports|August 6, 2017
Targeting primary acute myeloid leukemia with a new CXCR4 antagonist IgG1 antibody (PF-06747143)Yanyan Zhang, Erika Saavedra, Ruoping Tang, et al.
Bioconjugate Chemistry|February 3, 2017
Improved Lysosomal Trafficking Can Modulate the Potency of Antibody Drug ConjugatesRachel M DeVay, Kathy Delaria, Guoyun Zhu, et al.
Journal of Translational Medicine|April 24, 2025
MUC18-Directed chimeric antigen receptor T cells for the treatment of mucosal melanomaFenghao Zhang, Haizhen Du, Kaiping Liu, et al.
Molecular Cancer Therapeutics|April 17, 2026
ADCE-T02 - a Next Generation Antibody Drug Conjugate Targeting Tissue Factor Demonstrates Superior Preclinical Efficacy and TolerabilityThomas T Poulsen, Olga Ilina, Jonathan H Wardman, et al.
The Journal of Organic Chemistry|October 13, 2020
One-Pot CuI/DBU-Catalyzed Carboxylative Cyclization toward Oxazolidinones Using Recyclable Molecular Sieves as Efficient Promoters for Fixation of CO<sub>2</sub> in Water MediumYu-Te Liu, Chi-Wei Cheng, Huan-Chang Lu, et al.
Cancer Research|September 5, 2023
A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody-Drug Conjugate for Targeting MelanomaJing Shi, Tao Jiao, Qian Guo, et al.
Molecular Cancer Therapeutics|September 2, 2016
RN927C, a Site-Specific Trop-2 Antibody-Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor ModelsPavel Strop, Thomas-Toan Tran, Magdalena Dorywalska, et al.
Pageof 9